Search filters

List of works by Veronika Navrkalova

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres

scientific article published on 16 June 2016

ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.

scientific article published on 12 April 2013

Ability to downregulate the level of cyclin-dependent kinase inhibitor p27Kip1 after DNA damage is retained in chronic lymphocytic leukemia cells with functional ATM/p53 signaling pathway

scientific article

Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification

scientific article

Bioinformatic strategies for the analysis of genomic aberrations detected by targeted NGS panels with clinical application

scientific article published on 31 March 2021

Distinct in vitro sensitivity of p53-mutated and ATM-mutated chronic lymphocytic leukemia cells to ofatumumab and rituximab.

scientific article published on 23 June 2014

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.

scientific article published on 28 November 2016

Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia

scientific article

Oxidative stress as a therapeutic perspective for ATM-deficient chronic lymphocytic leukemia patients

scientific article published on August 2015

Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

scientific article

Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients

scientific article published on 29 July 2016

Specific p53 mutations do not impact results of alemtuzumab therapy among patients with chronic lymphocytic leukemia

scientific article published on 01 March 2012

Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting

scientific article

The impact of SF3B1 mutations in CLL on the DNA-damage response

scientific article

The p53 pathway induction is not primarily dependent on Ataxia Telangiectasia Mutated (ATM) gene activity after fludarabine treatment in chronic lymphocytic leukemia cells.

scientific article published in July 2013

[Molecular Prognostic Markers and Their Clinical Relevance in Chronic Lymphocytic Leukemia]

scientific article published on 01 January 2015